Puma Biotechnology (PBYI) Gross Profit (2017 - 2025)
Historic Gross Profit for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $42.3 million.
- Puma Biotechnology's Gross Profit fell 1777.24% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year decrease of 338.88%. This contributed to the annual value of $166.1 million for FY2024, which is 398.43% down from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's Gross Profit is $42.3 million, which was down 1777.24% from $40.1 million recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's Gross Profit peaked at $70.8 million during Q4 2022, and registered a low of $33.0 million during Q1 2024.
- Moreover, its 5-year median value for Gross Profit was $42.7 million (2023), whereas its average is $44.3 million.
- Within the past 5 years, the most significant YoY rise in Puma Biotechnology's Gross Profit was 6291.93% (2022), while the steepest drop was 4914.59% (2022).
- Quarter analysis of 5 years shows Puma Biotechnology's Gross Profit stood at $43.5 million in 2021, then skyrocketed by 62.92% to $70.8 million in 2022, then tumbled by 32.42% to $47.9 million in 2023, then decreased by 5.64% to $45.2 million in 2024, then fell by 6.32% to $42.3 million in 2025.
- Its last three reported values are $42.3 million in Q3 2025, $40.1 million for Q2 2025, and $35.5 million during Q1 2025.